COMP <GO>
PVH vs TMO // ENTERPRISE SCALE & MARKET CAP
PVH Corp. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PVH 5
— TMO 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $90.19 (+2.18%) • MKT CAP: $4.07B
market-cap
$4.07B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PVH VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PVH | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.50% | 41.00% | +16.50 | PVH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | 9.30% | -6.40 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.1x | 30.4x | -14.30 | PVH | /valuation <GO> |
| Free Cash Flow Yield | 13.22% | 2.40% | +10.82 | PVH | /fcf-yield <GO> |
| Operating Margin | 2.60% | 17.40% | -14.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 0.30% | 15.10% | -14.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 3.40% | 3.90% | -0.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.11 | 4.50 | -2.39 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.3 | 59.1 | +12.15 | PVH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.94 | +0.14 | PVH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 36.3x | +103.70 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $4.07B | $262.22B | -$258.14B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PVH REV | TMO REV | PVH GROSS % | TMO GROSS % | PVH FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.95B | $44.56B | 57.5% | 44.0% | $538.4M | $6.29B |
| FY 2024 | $8.65B | $42.88B | 59.4% | 44.0% | $582.2M | $7.27B |
| FY 2023 | $9.22B | $42.86B | 44.0% | 44.0% | $554.6M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PVH // BETA 1.08
TMO // BETA 0.94